Literature DB >> 12507511

Secreted phospholipases A2 induce the expression of chemokines in microvascular endothelium.

Grietje Ch Beck1, Benito A Yard, Jutta Schulte, Markus Haak, Klaus van Ackern, Fokko J van der Woude, Marietta Kaszkin.   

Abstract

Acute respiratory distress syndrome (ARDS) is characterized by alterations in microvascular permeability. In ARDS secreted phospholipase A(2) (sPLA(2)) IB and IIA are found to be highly upregulated. In this study, we therefore investigated the influence of exogenously added sPLA(2)-IB and sPLA(2)-IIA on the production of chemokines and adhesion molecules in lung microvascular endothelial cells (LMVEC). Treatment of LMVEC with sPLA(2)s resulted in a significant increase in the production of chemokines and adhesion molecules due to an increased expression of their mRNA and in an enhanced release of oleic acid. The upregulation of chemokines and adhesion molecules by LPS was stronger in the presence of sPLA(2). Activation of NF-kappaB occurred upon stimulation with sPLA(2). Moreover the MAPkinase pERK seems to be involved since a specific pERK inhibitor, e.g., U0126, but not a p38Kinase inhibitor, e.g., SB203580 prevented sPLA(2)-induced chemokine upregulation. Our data therefore suggest that LMVEC are a highly sensitive target for the direct action of extracellular sPLA(2)s.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507511     DOI: 10.1016/s0006-291x(02)02920-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Inhibitory Effect of FXa on Secretory Group IIA Phospholipase A2.

Authors:  Sae-Kwang Ku; Jong-Sup Bae
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 2.  Multiple roles of phospholipase A2 during lung infection and inflammation.

Authors:  Bryan P Hurley; Beth A McCormick
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

3.  Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro.

Authors:  Steven M Dudek; Nilda M Muñoz; Anjali Desai; Christopher M Osan; Angelo Y Meliton; Alan R Leff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-06       Impact factor: 6.914

4.  Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway.

Authors:  Qingquan Luo; Hao Lin; Xiangyun Ye; Jia Huang; Shun Lu; Lin Xu
Journal:  Int J Clin Oncol       Date:  2014-10-28       Impact factor: 3.402

5.  Inhibitory Effect of Orientin on Secretory Group IIA Phospholipase A2.

Authors:  Jong-Sup Bae
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

6.  Secretory phospholipase A2 in patients with coronary artery disease.

Authors:  Luciana Moreira Lima; Maria das Graças Carvalho; Cirilo Pereira da Fonseca Neto; José Carlos Faria Garcia; Marinez Oliveira Sousa
Journal:  J Thromb Thrombolysis       Date:  2009-05-17       Impact factor: 2.300

7.  Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Francesca Gotsch; Lami Yeo; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-06

8.  Lung mast cells are a source of secreted phospholipases A2.

Authors:  Massimo Triggiani; Giorgio Giannattasio; Cecilia Calabrese; Stefania Loffredo; Francescopaolo Granata; Alfonso Fiorello; Mario Santini; Michael H Gelb; Gianni Marone
Journal:  J Allergy Clin Immunol       Date:  2009-07-09       Impact factor: 10.793

9.  Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFalpha-stimulated human endothelial cells.

Authors:  K Sonoki; M Iwase; N Sasaki; S Ohdo; S Higuchi; Y Takata; M Iida
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

Review 10.  Acute phase reactants as novel predictors of cardiovascular disease.

Authors:  M S Ahmed; A B Jadhav; A Hassan; Qing H Meng
Journal:  ISRN Inflamm       Date:  2012-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.